Intervention Protocol

Hypolipidemic and antihypertensive drugs for prevention of cardiovascular complications in patients with rheumatoid arthritis

  1. Barbora de Courten2,
  2. Melissa N Barber1,*,
  3. Renea V Johnston3,
  4. Danny Liew4,
  5. Maximilian de Courten5,
  6. Sharon van Doornum6,
  7. Christopher Reid5,
  8. Rachelle Buchbinder3

Editorial Group: Cochrane Musculoskeletal Group

Published Online: 16 JUL 2008

Assessed as up-to-date: 12 MAY 2008

DOI: 10.1002/14651858.CD007326


How to Cite

de Courten B, Barber MN, Johnston RV, Liew D, de Courten M, van Doornum S, Reid C, Buchbinder R. Hypolipidemic and antihypertensive drugs for prevention of cardiovascular complications in patients with rheumatoid arthritis (Protocol). Cochrane Database of Systematic Reviews 2008, Issue 3. Art. No.: CD007326. DOI: 10.1002/14651858.CD007326.

Author Information

  1. 1

    Baker Heart Research Institute, Preventative Cardiology, Melbourne, VIC, Australia

  2. 2

    Baker Heart Research Institute, Monash University, Department of Epidemiology and Preventive Medicine, Melbourne, Victoria, Australia

  3. 3

    Department of Epidemiology and Preventive Medicine, Monash University, Monash Department of Clinical Epidemiology at Cabrini Hospital, Malvern, Victoria, Australia

  4. 4

    University of Melbourne, Department of Medicine, St Vincent's Hospital, Fitzroy, VIC, Australia

  5. 5

    Monash University, Department of Epidemiology and Preventive Medicine, Melbourne, VIC, Australia

  6. 6

    Royal Melbourne Hospital, Department of Medicine, Parkville, VIC, Australia

*Melissa N Barber, Preventative Cardiology, Baker Heart Research Institute, PO Box 6492, St Kilda Road Central, Melbourne, VIC, 8008, Australia. Melissa.Barber@baker.edu.au.

Publication History

  1. Publication Status: New
  2. Published Online: 16 JUL 2008

SEARCH

 

Abstract

  1. Top of page
  2. Abstract

This is the protocol for a review and there is no abstract. The objectives are as follows:

To review the efficacy and safety of hypolipidemic and antihypertensive therapy in preventing cardiovascular events in rheumatoid arthritis.